Precision, Pressure, and People: Leadership in Pharma

Precision, Pressure, and People: Leadership in Pharma

Over 30 years of working with leaders across diverse industries, I have found that many of the challenges leaders face are universal in nature and cut across industries. This, however, does not mean there are no people challenges unique to certain sectors. In my experience working within both pharmaceutical and diagnostic environments, I have consistently observed a set of leadership and cultural tensions that, if left unaddressed, limit performance and threaten sustainable success.

On the surface, these organisations are highly capable. They are filled with intelligent, technically excellent, and deeply experienced professionals. Technical success in these environments is built on specialist knowledge, precision, compliance, and problem-solving. Leadership effectiveness, however, requires something different — self-awareness, emotional control, accountability, clarity of thought under pressure, and the ability to influence and develop others. These are capabilities that are rarely taught or expected early on.

In many of the environments I’ve worked in, leadership roles are earned through technical excellence. The best scientist, the most experienced analyst, or the highest performer naturally progresses into management. But what makes someone successful technically is not necessarily what makes them effective as a leader. It is not that people lack capability or intelligence — it is that many have never been developed in a different dimension. The gap is not competence — it is self-leadership.

This, in my opinion, forms part of the core leadership challenge within the industry.

When pressure rises and things start going wrong, many leaders understandably revert to what they know best — technical problem-solving. Yet leadership under pressure requires emotional intelligence and personal mastery. Without it, we often see defensiveness, inconsistency in leadership behaviour, difficulty managing self before managing others, and an over-reliance on escalation and control.

The result is often firefighting, constant escalation, and fear-driven decision-making. In highly regulated environments, the fear of mistakes and the consequences of non-compliance can become deeply embedded in the culture. Decisions are then driven by urgency rather than clarity and proactive planning. Staff members and middle management are frequently excluded from decisions that directly affect their daily realities, resulting in reduced ownership, disengagement, and cultures where people comply, but seldom contribute fully.

These environments demand extraordinary levels of precision and compliance. However, when pressure increases, leaders can easily become reactive rather than intentional, making short-term and tactical decisions instead of thinking clearly and strategically.

What I have consistently observed is not a lack of capability, but often a lack of clarity and structured thinking under pressure. Technical expertise is generally very high, but self-leadership remains a constraint. Emotional intelligence is not a “soft skill” in this environment — it is a core performance capability, yet one that is often underdeveloped or insufficiently prioritised.

Another interesting contradiction exists within many pharmaceutical businesses. These organisations generally have a very noble and meaningful purpose. Their work improves health, serves humanity, and in many cases literally saves lives. In less regulated industries, purpose often becomes a unifying force that aligns departments and inspires people. Yet in highly technical and compliance-driven environments, I have often found that the personal connection to that purpose becomes weakened.

External pressures — legislation, audits, targets, competition, compliance demands, and operational pressures — begin to dominate thinking and behaviour. Leaders may communicate the right messages, yet under pressure, true priorities are ultimately revealed through behaviour and decision-making.

Martin VanTrieste, former Chief Quality Officer at Amgen and author of Protecting Patients At All Costs: The Drug Watch Dogs, highlights this tension powerfully. He describes situations where the next potential billion-dollar product is racing toward U.S. Food and Drug Administration (FDA) approval, or where companies are under immense pressure to ensure their generic drug is first to file with the FDA — despite a batch not meeting the required quality standards. Rejecting the batch is necessary to protect patients, yet doing so can result in major financial losses, production delays, and disruption to market supply. The decision between safeguarding patient health and preventing business loss becomes emotionally and professionally challenging, particularly given the potential consequences for the organisation and the market.

The contradiction is striking. Although the organisation’s stated purpose may be deeply meaningful, many leaders and staff begin operating transactionally, driven primarily by targets, deadlines, and the pressure to avoid mistakes while increasing profitability. Compliance and profits become the dominant focus, while passion, ownership, creativity, and engagement gradually diminish. People begin feeling controlled rather than empowered and work eventually becomes activity without meaning.

Organisations invest heavily in technical training and professional development, yet very little of this consistently translates into sustained behavioural change. Even when companies invest in leadership or soft-skills development, the sessions themselves may be excellent, but there is often little follow-through, reinforcement, coaching, or accountability for implementation afterwards.

The real gap is therefore not learning — it is implementation.

The challenge is not knowledge, capability, or even intent. The challenge is the consistent application of effective leadership character behaviour under pressure.

Over time, this reality is what shaped much of our philosophy at MCA. MCA stands for Manage Change in Attitude, and our belief has always been that sustainable transformation is an inside-out process. Real change happens when leaders first develop the internal capacity to lead themselves well — particularly under pressure.

Our focus has therefore never simply been on transferring information or delivering training events. It has been on helping leaders build the mindsets, emotional maturity, accountability, and behavioural consistency required to create healthy, high-performing cultures. Cultures where people are united around a shared purpose, where leadership behaviour builds trust rather than fear, and where values are demonstrated consistently in everyday decisions and actions.

These organisations do not need more information. They need transformation in how leadership shows up every day.

We have learned that this shift does not come from more theory, more presentations, or more policies. It comes from building leaders who can think clearly under pressure, lead themselves effectively, and translate intention into consistent action.

With Love and Respect Stefan Lessing